C4 Therapeutics (CCCC) Change in Account Payables (2019 - 2025)
Historic Change in Account Payables for C4 Therapeutics (CCCC) over the last 7 years, with Q3 2025 value amounting to -$885000.0.
- C4 Therapeutics' Change in Account Payables fell 25000.0% to -$885000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$172000.0, marking a year-over-year decrease of 17610.62%. This contributed to the annual value of -$119000.0 for FY2024, which is 14358.97% down from last year.
- Latest data reveals that C4 Therapeutics reported Change in Account Payables of -$885000.0 as of Q3 2025, which was down 25000.0% from $1.5 million recorded in Q2 2025.
- In the past 5 years, C4 Therapeutics' Change in Account Payables registered a high of $1.5 million during Q2 2025, and its lowest value of -$2.0 million during Q1 2021.
- In the last 5 years, C4 Therapeutics' Change in Account Payables had a median value of -$176000.0 in 2024 and averaged -$229157.9.
- The largest annual percentage gain for C4 Therapeutics' Change in Account Payables in the last 5 years was 31454.55% (2025), contrasted with its biggest fall of 45439.56% (2025).
- C4 Therapeutics' Change in Account Payables (Quarter) stood at $760000.0 in 2021, then plummeted by 241.58% to -$1.1 million in 2022, then skyrocketed by 115.71% to $169000.0 in 2023, then crashed by 204.14% to -$176000.0 in 2024, then crashed by 402.84% to -$885000.0 in 2025.
- Its Change in Account Payables stands at -$885000.0 for Q3 2025, versus $1.5 million for Q2 2025 and -$645000.0 for Q1 2025.